LANE COOK: Open Payments
NPI 1174509590 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 75 payments from 12 companies in 2025. Trend: 2023 $2,263 · 2024 $1,832 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $273 |
| Teva Pharmaceuticals USA, Inc. | 12 | $218 |
| Otsuka America Pharmaceutical, Inc. | 11 | $161 |
| Alkermes, Inc. | 7 | $152 |
| Vanda Pharmaceuticals Inc. | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $132 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $48 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, REXULTI, TRINTELLIX, SPRAVATO, HETLIOZ, LYBALVI.
Industry payments across TN — which companies pay providers there.
